This protocol is judged by an institutional overview board, an impartial group that opinions any scientific trials involving humans. If a study consists of a Routine I drug, after the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) selection within the FDA.Subsequently, medicat